VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease
Clinical trial NCT02898753 · TERMINATED
Trial details
- NCT number
- NCT02898753
- Sponsor
- Valerion Therapeutics, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2020-03-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.